GLP1Score — Free GLP-1 Eligibility Assessment for India
India's most comprehensive GLP-1 eligibility assessment. Our 30-question clinical assessment, built on 20 peer-reviewed studies, evaluates your eligibility across 6 medical dimensions. Compare 18+ generic semaglutide brands from ₹1,290/month. 100% free.
How It Works
Answer 30 questions about your body, health, safety profile, readiness, access, and motivation. Get a personalized eligibility score (0-100), red flag alerts, brand recommendations matched to your budget, and a downloadable PDF report for your doctor.
Generic Semaglutide Brands in India (2026)
Since March 2026, over 40 generic semaglutide brands are available in India. Prices range from ₹1,290/month (Natco Semanat vial) to ₹10,850/month (Novo Wegovy pen).
- Natco Semanat — ₹1,290/month (vial)
- Alkem Semasize — ₹1,800/month (pen)
- Zydus Semaglyn — ₹2,200/month (pen)
- Glenmark GLIPIQ — ₹2,800/month (pen)
- Eris Sundae — ₹3,000/month (pen)
- Sun Pharma Noveltreat — ₹3,200/month (pen)
- Dr. Reddy's Obeda — ₹4,200/month (pen)
- Rybelsus — ₹4,500/month (oral tablet)
- Novo Ozempic — ₹8,800/month (pen)
- Novo Wegovy — ₹10,850/month (pen)
Frequently Asked Questions
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist drug used for Type 2 diabetes and weight management. Originally sold as Ozempic and Wegovy by Novo Nordisk, generic versions are now available in India from over 40 companies since the patent expired in March 2026. It is administered as a once-weekly injection.
What is the cheapest semaglutide brand in India?
Natco Semanat at approximately ₹1,290 per month in multi-dose vial format. The cheapest pen format is Alkem Semasize at around ₹1,800 per month.
Am I eligible for semaglutide in India?
You may be eligible if your BMI is 25 or above (Indian cutoff), or BMI 23 or above with at least one weight-related condition such as Type 2 diabetes, hypertension, PCOS, or fatty liver. South Asian BMI cutoffs are lower than Western standards.
What are the common side effects of semaglutide?
Nausea (44%), diarrhea (30%), constipation (24%), vomiting (24%), and abdominal pain (20%). Most are mild and resolve within 2-4 weeks at each dose level. Slow dose escalation significantly reduces severity.
Do I need a prescription for semaglutide in India?
Yes. Semaglutide is a Schedule H drug in India. It must be prescribed by a licensed doctor. The DCGI has been cracking down on unauthorized sales since March 2026.
How much weight can I lose with semaglutide?
The STEP 1 trial showed an average of 14.9% body weight loss over 68 weeks. For a 90 kg person, that is roughly 13-15 kg. Individual results vary based on diet, exercise, and adherence.
Are generic semaglutide brands as effective as Ozempic?
Yes. All DCGI-approved generics contain the same active molecule. Dr. Reddy's conducted a Phase 3 trial with 312 participants showing their generic Obeda is non-inferior to Ozempic in efficacy.
What BMI do I need for GLP-1 therapy in India?
South Asian cutoffs: BMI 25+ without comorbidities, or BMI 23+ with at least one weight-related condition. Western cutoffs of 30/27 underestimate risk in Indians.
Take the Free GLP-1 Eligibility Assessment | Read Our Guides | Compare Brands